Literature DB >> 1355009

Differential susceptibility of cultured human melanoma cell lines to enhancement by retinoic acid of intercellular adhesion molecule 1 expression.

Z Wang1, Y Cao, C M D'Urso, S Ferrone.   

Abstract

The potential role of intercellular adhesion molecule 1 (ICAM-1) in the biology of human melanoma cells has stimulated interest in the characterization of its modulation. The present study has shown that the differentiating agent retinoic acid (RA) up-regulates ICAM-1 expression by melanoma cells in a dose- and time-dependent fashion. The enhancement of ICAM-1 cell surface expression is paralleled by an increase in ICAM-1 mRNA. Therefore, ICAM-1 represents an additional gene which may be transcriptionally regulated by RA. The five melanoma cell lines tested displayed a differential susceptibility to the modulation of ICAM-1 expression by RA, since the cell line MeWo did not change in its ICAM-1 expression following incubation with RA. Nevertheless, RA-insensitive as well as RA-sensitive melanoma cell lines displayed a higher increase in ICAM-1 expression following incubation with RA and cytokines than following incubation with each of them. Analysis of the distribution in the melanoma cell lines of retinoic acid receptors (RARs) showed a relationship between susceptibility to a RA-mediated increase of ICAM-1 expression and RAR beta expression, suggesting that the latter receptor may play a role in the phenomenon. RAR alpha and RAR gamma were present in RA-sensitive and -insensitive melanoma cell lines, suggesting that they play a role in the enhancement by RA of cytokine-mediated up-regulation of ICAM-1 expression. The melanoma cell lines we have described may represent a useful system for investigating the role of RAR in the regulation of gene expression and the mechanism(s) which underlie this effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355009

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T-cell immunity.

Authors:  Wei Yin; Yan Song; Qing Liu; Yunyun Wu; Rui He
Journal:  Immunology       Date:  2017-06-29       Impact factor: 7.397

2.  Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells.

Authors:  J Gille; L L Paxton; T J Lawley; S W Caughman; R A Swerlick
Journal:  J Clin Invest       Date:  1997-02-01       Impact factor: 14.808

3.  Aberrant distribution of junctional complex components in retinoic acid receptor alpha-deficient mice.

Authors:  Sanny S W Chung; Cindy Choi; Xiangyuan Wang; Loretta Hallock; Debra J Wolgemuth
Journal:  Microsc Res Tech       Date:  2010-06       Impact factor: 2.769

4.  The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.

Authors:  C L Alexander; M Edward; R M MacKie
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

5.  Retinoic acid and cancer treatment.

Authors:  Mei-Chih Chen; Shih-Lan Hsu; Ho Lin; Tsung-Ying Yang
Journal:  Biomedicine (Taipei)       Date:  2014-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.